NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,565,000 | -60.2% | 254,473 | -17.8% | 0.11% | -60.8% |
| Q4 2021 | $8,961,000 | -73.5% | 309,540 | -72.5% | 0.29% | -75.6% |
| Q3 2021 | $33,754,000 | -35.3% | 1,126,640 | -42.8% | 1.17% | -39.8% |
| Q2 2021 | $52,210,000 | -16.8% | 1,967,950 | -2.5% | 1.95% | -29.9% |
| Q1 2021 | $62,771,000 | +23.6% | 2,019,019 | +30.8% | 2.78% | +2.0% |
| Q4 2020 | $50,767,000 | +22.0% | 1,544,019 | +29.5% | 2.73% | -8.0% |
| Q3 2020 | $41,618,000 | – | 1,192,156 | – | 2.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
| DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
| Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
| Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
| Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
| Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
| Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
| AtonRa Partners | 24,227 | $190,424 | 0.40% |
| WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |